Cargando…
Glioblastoma patients in Slovenia from 1997 to 2008
BACKGROUND: Glioblastoma is the most common primary brain tumour. It has a poor prognosis despite some advances in treatment that have been achieved over the last ten years. In Slovenia, 50 to 60 glioblastoma patients are diagnosed each year. In order to establish whether the current treatment optio...
Autores principales: | Smrdel, Uros, Kovac, Viljem, Popovic, Mara, Zwitter, Matjaz |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Association of Radiology and Oncology
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3908851/ https://www.ncbi.nlm.nih.gov/pubmed/24587783 http://dx.doi.org/10.2478/raon-2014-0002 |
Ejemplares similares
-
Long-term survival in glioblastoma: methyl guanine methyl transferase (MGMT) promoter methylation as independent favourable prognostic factor
por: Smrdel, Uros, et al.
Publicado: (2016) -
Improved survival after introduction of chemotherapy for malignant pleural mesothelioma in Slovenia: Population-based survey of 444 patients
por: Kovac, Viljem, et al.
Publicado: (2012) -
Intermittent Chemotherapy and Erlotinib for Nonsmokers or Light
Smokers with Advanced Adenocarcinoma of the Lung: A Phase II Clinical Trial
por: Zwitter, Matjaz, et al.
Publicado: (2011) -
Induction gemcitabine in standard dose or prolonged low-dose with cisplatin followed by concurrent radiochemotherapy in locally advanced non-small cell lung cancer: a randomized phase II clinical trial
por: Vrankar, Martina, et al.
Publicado: (2014) -
Glioblastoma in Patients over 70 Years of Age
por: Smrdel, Uros, et al.
Publicado: (2018)